パニック障害治療のグローバル臨床試験動向(2014年下半期)...市場調査レポートについてご紹介

【英文タイトル】Panic Disorders Global Clinical Trials Review, H2, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Panic Disorders 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Panic Disorders to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Panic Disorders to Central Nervous System Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Panic Disorders 24
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Panic Disorders Therapeutics Clinical Trials 29
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Pfizer Inc. 32
Clinical Trial Overview of Pfizer Inc. 32
GlaxoSmithKline plc 34
Clinical Trial Overview of GlaxoSmithKline plc 34
ZonMw 35
Clinical Trial Overview of ZonMw 35
Bluefish Pharmaceuticals AB 36
Clinical Trial Overview of Bluefish Pharmaceuticals AB 36
Teva Pharmaceutical Industries Limited 37
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 37
Alexza Pharmaceuticals, Inc. 38
Clinical Trial Overview of Alexza Pharmaceuticals, Inc. 38
Actavis plc 39
Clinical Trial Overview of Actavis plc 39
Abiogen Pharma S.p.A. 40
Clinical Trial Overview of Abiogen Pharma S.p.A. 40
Clinical Trial Overview of Top Institutes / Government 41
National Institute of Mental Health 41
Clinical Trial Overview of National Institute of Mental Health 41
Massachusetts General Hospital 42
Clinical Trial Overview of Massachusetts General Hospital 42
The University of New South Wales 43
Clinical Trial Overview of The University of New South Wales 43
Charite – Universitatsmedizin Berlin 44
Clinical Trial Overview of Charite – Universitatsmedizin Berlin 44
University of Pittsburgh 45
Clinical Trial Overview of University of Pittsburgh 45
Samsung Medical Center 46
Clinical Trial Overview of Samsung Medical Center 46
Maastricht University Medical Center 47
Clinical Trial Overview of Maastricht University Medical Center 47
Karolinska Institute 48
Clinical Trial Overview of Karolinska Institute 48
Federal University of Rio de Janeiro 49
Clinical Trial Overview of Federal University of Rio de Janeiro 49
Maastricht University 50
Clinical Trial Overview of Maastricht University 50
Five Key Clinical Profiles 51
Appendix 79
Abbreviations 79
Definitions 79
Research Methodology 80
Secondary Research 80
About GlobalData 81
Contact Us 81
Disclaimer 81
Source 81


【レポート販売概要】

■ タイトル:パニック障害治療のグローバル臨床試験動向(2014年下半期)
■ 英文:Panic Disorders Global Clinical Trials Review, H2, 2014
■ 発行日:2014年7月28日
■ 調査会社:GlobalData
■ 商品コード:GDHC2257CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。